Spruce Biosciences

$7.2M revenue • 40 employees

Last Updated Oct 3, 2026

Company Overview

Company Name

Spruce Biosciences

Approx. Annual Revenue

$7.2M

Employees

40

Established

2014

About Spruce Biosciences

Spruce Biosciences is a company that develops and commercializes novel therapies for rare endocrine disorders and neurological conditions with significant unmet medical needs. The company has approximately 11 employees and is focused on advancing its lead product candidate, tildacerfont, for the treatment of classic congenital adrenal hyperplasia, polycystic ovary syndrome, and major depressive disorder.

Business Profile

Read from the Spruce Biosciences website on Oct 13, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
8/10 · Current copyright 2026; Complete company and pipeline info
Footer copyright year
2026

Biotech & Life Sciences Companies near CA

Browse all Biotech & Life Sciences companies in California →

Frequently Asked Questions about Spruce Biosciences

Categories

Technologies Used

Social Profiles

Key Decision Makers

Javier Szwarcberg Chief Executive Officer
LinkedIn
Omnya Shiglawi Clinical Research Associate
LinkedIn
Shawn Saeturn Clinical Research Associate
LinkedIn
Ivona Zielinska Senior Clinical Trial Manager
LinkedIn